Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-15

FDA Approved: MEPERIDINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.’s supplemental application for Meperidine Hydrochloride, approving a generic version of this opioid analgesic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEPERIDINE HYDROCHLORIDE (Meperidine hydrochloride)

Snippet

SUPPL AP for MEPERIDINE HYDROCHLORIDE (MEPERIDINE HYDROCHLORIDE)